New insight on managing fungal meningitis

As the number of fungal meningitis cases continues to rise, physicians across the country are faced with how best to provide the early treatment that can save lives.

A University of Michigan Health System infectious disease expert is the lead author of a report detailing how the outbreak evolved and the complexities of providing anti-fungal treatments.

Carol F. Kauffman, M.D., has served as an advisor to the as it investigates the more than 200 cases of linked to a contaminated steroid injected in patients for pain relief. A large number of patients in the outbreak are older adults, many of whom have substantial coexisting illnesses that make care decisions challenging.

None of the contaminated medicines were administered by the University of Michigan Hospitals and Health Centers.

Kauffman, a former board member of the Infectious Diseases Society of America, has focused her research career on diagnosis and treatment of fungal infections, especially in immunocompromised hosts, and prevention and treatment of infections in older adults.

"Treatment recommendations will certainly evolve as clinicians gain more experience with managing these infections," says Kauffman, chief of infectious diseases at the VA Ann Arbor Healthcare System and professor of internal medicine at the University of Michigan Health System.

"Given the (lack) of data pertaining to treatment and the complexity of management, decisions about the treatment of patients with proven or suspected infection should be made with the input of an specialist," she says.

Patients found to be infected are being treated with a fairly high dose of , which can cause side effects including visual disturbances, confusion, hallucinations, nausea, and liver test abnormalities.

"There is appropriate concern about the toxicity of voriconazole, particularly at the doses recommended to treat meningitis," Kauffman says. "Visual hallucinations have been especially problematic in patients treated in this outbreak and appear to be related to high serum levels. Decreasing the dose of the drug will obviate this effect."

There are also significant drug-drug interactions. Administering voriconazole to patients who are already taking agents such as blood thinners, statins, benzodiazepines, and certain seizure medicines, to name just a few, should be done with care, Kauffman and others advise. Doctors should play close attention to decreasing the doses of other medicines and monitoring blood levels.

The CDC reports the death toll has risen to 20 people with 254 fungal meningitis cases confirmed in 16 states, including Michigan. Infections have only been found in patients injected with methylprednisolone acetate from the New England Compounding Center, which has been recalled.

The CDC advises patients who feel ill and are concerned they were injected with recalled products to contact their physicians. Doctors should be aware of symptoms of fungal meningitis and seek rapid diagnosis and treatment to prevent serious complications and deaths.

Typically in this outbreak, symptoms – such as headache, fever, nausea, and neck stiffness—have appeared one to four weeks following injection. But fungal infections can be slow to develop and patients should be vigilant about onset of symptoms for up to two months.

More information: New England Journal of Medicine. Oct, 19, 2012DOI: 10.1056/NEJMra1212617

add to favorites email to friend print save as pdf

Related Stories

US: Pharmacy's other drugs may be causing illness

Oct 15, 2012

Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said, as they urged doctors to contact patients who got any kind of injection from the company.

US warns meningitis cases could rise

Oct 12, 2012

US authorities have managed to contact most of the thousands of people exposed to the tainted drug blamed for a meningitis outbreak that has killed 14, but warned the number of infections could rise.

7 dead in spreading US meningitis outbreak

Oct 08, 2012

At least seven people have died and 91 have fallen ill in the United States in a worsening meningitis outbreak tied to a contaminated drug, updated figures showed Sunday.

Recommended for you

UN chief: Ebola cases in Mali a 'deep concern'

2 hours ago

The United Nations chief warned Friday that Ebola may be easing in part of West Africa but is still hitting hard in other areas and outpacing the international response.

Ebola death toll rises to 5,459: WHO

8 hours ago

The World Health Organization said Friday that 5,459 people had so far died of Ebola out of a total 15,351 cases of infection in eight countries since late December 2013.

Flu season off to a slow start ... for now

11 hours ago

(HealthDay)—This year's flu season is off to a slow but detectable start. And it appears to be a typical one that's likely to peak in January or February, a leading U.S. health official says.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.